Global Botulinum Toxin Type A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Botulinum Toxin Type A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
Botulinum Toxin Type A report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Botulinum Toxin Type A market is projected to reach US$ 8335.1 million in 2033, increasing from US$ 6563.4 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Demand from Cosmetic Applications and Therapeutic Applications are the major drivers for the industry.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Botulinum Toxin Type A market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Segment by Type
50 Units
100 Units
200 Units
Cosmetic Applications
Therapeutic Applications
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Botulinum Toxin Type A market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Botulinum Toxin Type A, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Botulinum Toxin Type A industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Botulinum Toxin Type A in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Botulinum Toxin Type A introduction, etc. Botulinum Toxin Type A Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Botulinum Toxin Type A market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Botulinum Toxin Type A report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Botulinum Toxin Type A market is projected to reach US$ 8335.1 million in 2033, increasing from US$ 6563.4 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Demand from Cosmetic Applications and Therapeutic Applications are the major drivers for the industry.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Botulinum Toxin Type A market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Segment by Type
50 Units
100 Units
200 Units
Segment by Application
Cosmetic Applications
Therapeutic Applications
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Botulinum Toxin Type A market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Botulinum Toxin Type A, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Botulinum Toxin Type A industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Botulinum Toxin Type A in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Botulinum Toxin Type A introduction, etc. Botulinum Toxin Type A Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Botulinum Toxin Type A market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices